Unresolved disorder model. using A ATOM 232 CA AASP 29 -0.188 -5.826 29.683 0.50 8.54 C Unresolved disorder model. using A ATOM 233 CA BASP 29 -0.184 -5.829 29.683 0.50 8.64 C Unresolved disorder model. using A ATOM 236 CB AASP 29 0.130 -7.023 30.581 0.50 9.27 C Unresolved disorder model. using A ATOM 237 CB BASP 29 0.150 -7.022 30.580 0.50 9.55 C Unresolved disorder model. using A ATOM 238 CG AASP 29 0.752 -8.185 29.819 0.50 10.32 C Unresolved disorder model. using A ATOM 239 CG BASP 29 -0.979 -8.034 30.655 0.50 11.16 C Unresolved disorder model. using A ATOM 240 OD1AASP 29 0.828 -8.136 28.577 0.50 9.99 O Unresolved disorder model. using A ATOM 241 OD1BASP 29 -1.530 -8.402 29.592 0.50 13.13 O Unresolved disorder model. using A ATOM 242 OD2AASP 29 1.164 -9.158 30.479 0.50 12.14 O Unresolved disorder model. using A ATOM 243 OD2BASP 29 -1.309 -8.463 31.778 0.50 14.49 O Unresolved disorder model. using A ATOM 378 CA ALEU 46 8.161 -5.570 10.765 0.50 7.20 C Unresolved disorder model. using A ATOM 379 CA BLEU 46 8.159 -5.600 10.734 0.50 7.17 C Unresolved disorder model. using A ATOM 382 CB ALEU 46 8.079 -4.111 11.263 0.50 6.87 C Unresolved disorder model. using A ATOM 383 CB BLEU 46 8.041 -4.114 11.098 0.50 6.96 C Unresolved disorder model. using A ATOM 384 CG ALEU 46 7.894 -2.961 10.261 0.50 6.73 C Unresolved disorder model. using A ATOM 385 CG BLEU 46 6.954 -3.441 10.242 0.50 6.55 C Unresolved disorder model. using A ATOM 386 CD1ALEU 46 6.447 -2.855 9.833 0.50 6.67 C Unresolved disorder model. using A ATOM 387 CD1BLEU 46 6.703 -2.004 10.652 0.50 6.46 C Unresolved disorder model. using A ATOM 388 CD2ALEU 46 8.346 -1.638 10.862 0.50 6.68 C Unresolved disorder model. using A ATOM 389 CD2BLEU 46 7.277 -3.546 8.752 0.50 6.42 C Unresolved disorder model. using A ATOM 430 CG AASP 51 9.950 -1.704 26.298 0.50 8.82 C Unresolved disorder model. using A ATOM 431 CG BASP 51 8.938 -0.482 27.378 0.50 8.95 C Unresolved disorder model. using A ATOM 432 OD1AASP 51 9.422 -2.816 26.528 0.50 10.85 O Unresolved disorder model. using A ATOM 433 OD1BASP 51 7.831 -0.700 27.912 0.50 11.53 O Unresolved disorder model. using A ATOM 434 OD2AASP 51 11.178 -1.495 26.400 0.50 12.02 O Unresolved disorder model. using A ATOM 435 OD2BASP 51 9.967 -0.209 28.025 0.50 11.46 O Unresolved disorder model. using A ATOM 677 CB ALEU 83 6.699 4.034 16.952 0.50 5.01 C Unresolved disorder model. using A ATOM 678 CB BLEU 83 6.612 4.066 16.994 0.50 5.03 C Unresolved disorder model. using A ATOM 679 CG ALEU 83 7.576 3.037 16.191 0.50 6.76 C Unresolved disorder model. using A ATOM 680 CG BLEU 83 7.286 2.843 16.407 0.50 6.81 C Unresolved disorder model. using A ATOM 681 CD1ALEU 83 6.983 1.622 16.242 0.50 6.65 C Unresolved disorder model. using A ATOM 682 CD1BLEU 83 8.164 2.225 17.446 0.50 7.50 C Unresolved disorder model. using A ATOM 683 CD2ALEU 83 7.759 3.484 14.765 0.50 5.77 C Unresolved disorder model. using A ATOM 684 CD2BLEU 83 6.199 1.862 16.007 0.50 5.17 C Unresolved disorder model. using A ATOM 755 CB AVAL 93 2.154 22.741 12.145 0.70 4.91 C Unresolved disorder model. using A ATOM 756 CB BVAL 93 2.074 22.677 12.141 0.30 4.89 C Unresolved disorder model. using A ATOM 757 CG1AVAL 93 1.779 24.085 11.548 0.70 7.46 C Unresolved disorder model. using A ATOM 758 CG1BVAL 93 3.132 23.293 13.023 0.30 4.94 C Unresolved disorder model. using A ATOM 759 CG2AVAL 93 0.991 22.102 12.924 0.70 4.58 C Unresolved disorder model. using A ATOM 760 CG2BVAL 93 1.234 23.772 11.515 0.30 6.08 C Unresolved disorder model. using A ATOM 1055 CA AILE 131 -22.914 27.804 26.182 0.50 11.65 C Unresolved disorder model. using A ATOM 1056 CA BILE 131 -22.878 27.887 26.332 0.50 11.72 C Unresolved disorder model. using A ATOM 1059 CB AILE 131 -23.345 26.667 25.182 0.50 11.30 C Unresolved disorder model. using A ATOM 1060 CB BILE 131 -23.387 26.491 25.864 0.50 11.79 C Unresolved disorder model. using A ATOM 1061 CG1AILE 131 -24.877 26.479 25.142 0.50 12.04 C Unresolved disorder model. using A ATOM 1062 CG1BILE 131 -23.165 26.278 24.370 0.50 10.46 C Unresolved disorder model. using A ATOM 1063 CG2AILE 131 -22.625 25.351 25.462 0.50 10.96 C Unresolved disorder model. using A ATOM 1064 CG2BILE 131 -24.858 26.288 26.239 0.50 12.20 C Unresolved disorder model. using A ATOM 1065 CD1AILE 131 -25.550 26.159 26.474 0.50 14.23 C Unresolved disorder model. using A ATOM 1066 CD1BILE 131 -23.274 24.825 23.951 0.50 9.11 C Unresolved disorder model. using A ATOM 1211 CA AILE 150 -12.026 31.243 8.431 0.50 9.47 C Unresolved disorder model. using A ATOM 1212 CA BILE 150 -12.026 31.235 8.436 0.50 9.57 C Unresolved disorder model. using A ATOM 1215 CB AILE 150 -12.653 29.830 8.341 0.50 9.19 C Unresolved disorder model. using A ATOM 1216 CB BILE 150 -12.634 29.810 8.381 0.50 9.30 C Unresolved disorder model. using A ATOM 1217 CG1AILE 150 -12.201 29.126 7.055 0.50 9.50 C Unresolved disorder model. using A ATOM 1218 CG1BILE 150 -11.989 28.986 7.255 0.50 9.77 C Unresolved disorder model. using A ATOM 1219 CG2AILE 150 -14.187 29.902 8.424 0.50 9.73 C Unresolved disorder model. using A ATOM 1220 CG2BILE 150 -14.165 29.860 8.259 0.50 10.06 C Unresolved disorder model. using A ATOM 1221 CD1AILE 150 -12.561 27.644 7.000 0.50 9.03 C Unresolved disorder model. using A ATOM 1222 CD1BILE 150 -12.295 29.476 5.844 0.50 10.46 C Unresolved disorder model. using A ATOM 1249 CA AGLU 154 -11.075 32.745 14.147 0.50 6.03 C Unresolved disorder model. using A ATOM 1250 CA BGLU 154 -11.080 32.751 14.147 0.50 6.15 C Unresolved disorder model. using A ATOM 1253 CB AGLU 154 -10.792 33.899 13.181 0.50 6.76 C Unresolved disorder model. using A ATOM 1254 CB BGLU 154 -10.830 33.917 13.193 0.50 7.18 C Unresolved disorder model. using A ATOM 1255 CG AGLU 154 -9.861 33.574 12.025 0.50 7.68 C Unresolved disorder model. using A ATOM 1256 CG BGLU 154 -9.866 33.641 12.071 0.50 9.54 C Unresolved disorder model. using A ATOM 1257 CD AGLU 154 -9.674 34.760 11.091 0.50 8.28 C Unresolved disorder model. using A ATOM 1258 CD BGLU 154 -9.722 34.843 11.168 0.50 12.72 C Unresolved disorder model. using A ATOM 1259 OE1AGLU 154 -10.490 35.709 11.159 0.50 8.64 O Unresolved disorder model. using A ATOM 1260 OE1BGLU 154 -9.066 35.828 11.579 0.50 12.56 O Unresolved disorder model. using A ATOM 1261 OE2AGLU 154 -8.716 34.756 10.288 0.50 9.02 O Unresolved disorder model. using A ATOM 1262 OE2BGLU 154 -10.284 34.806 10.052 0.50 15.39 O Unresolved disorder model. using A ATOM 1319 CA ASER 161 -8.109 31.804 24.126 0.50 7.56 C Unresolved disorder model. using A ATOM 1320 CA BSER 161 -8.106 31.767 24.139 0.50 7.65 C Unresolved disorder model. using A ATOM 1323 CB ASER 161 -7.428 32.651 23.054 0.50 8.07 C Unresolved disorder model. using A ATOM 1324 CB BSER 161 -7.328 32.505 23.046 0.50 8.04 C Unresolved disorder model. using A ATOM 1325 OG ASER 161 -6.989 31.854 21.981 0.50 8.09 O Unresolved disorder model. using A ATOM 1326 OG BSER 161 -6.064 32.941 23.515 0.50 9.69 O Unresolved disorder model. using A ATOM 1337 CB AARG 163 -12.769 31.330 28.270 0.50 8.42 C Unresolved disorder model. using A ATOM 1338 CB BARG 163 -12.758 31.294 28.248 0.50 8.46 C Unresolved disorder model. using A ATOM 1339 CG AARG 163 -13.676 32.506 27.934 0.50 9.42 C Unresolved disorder model. using A ATOM 1340 CG BARG 163 -13.812 32.375 28.465 0.50 9.92 C Unresolved disorder model. using A ATOM 1341 CD AARG 163 -15.136 32.187 28.194 0.50 10.74 C Unresolved disorder model. using A ATOM 1342 CD BARG 163 -14.144 33.112 27.176 0.50 11.29 C Unresolved disorder model. using A ATOM 1343 NE AARG 163 -15.980 33.351 27.926 0.50 10.77 N Unresolved disorder model. using A ATOM 1344 NE BARG 163 -15.349 33.930 27.311 0.50 14.18 N Unresolved disorder model. using A ATOM 1345 CZ AARG 163 -17.194 33.551 28.430 0.50 11.90 C Unresolved disorder model. using A ATOM 1346 CZ BARG 163 -15.610 35.010 26.585 0.50 14.39 C Unresolved disorder model. using A ATOM 1347 NH1AARG 163 -17.740 32.672 29.255 0.50 10.98 N Unresolved disorder model. using A ATOM 1348 NH1BARG 163 -14.749 35.424 25.660 0.50 13.97 N Unresolved disorder model. using A ATOM 1349 NH2AARG 163 -17.864 34.652 28.103 0.50 11.53 N Unresolved disorder model. using A ATOM 1350 NH2BARG 163 -16.736 35.684 26.787 0.50 16.66 N Unresolved disorder model. using A ATOM 1422 CA AASP 173 -12.030 12.779 29.821 0.50 7.35 C Unresolved disorder model. using A ATOM 1423 CA BASP 173 -12.020 12.784 29.821 0.50 7.42 C Unresolved disorder model. using A ATOM 1426 CB AASP 173 -11.237 11.880 30.786 0.50 8.53 C Unresolved disorder model. using A ATOM 1427 CB BASP 173 -11.201 11.937 30.797 0.50 8.62 C Unresolved disorder model. using A ATOM 1428 CG AASP 173 -11.417 10.395 30.494 0.50 9.47 C Unresolved disorder model. using A ATOM 1429 CG BASP 173 -12.033 11.444 31.949 0.50 10.39 C Unresolved disorder model. using A ATOM 1430 OD1AASP 173 -12.314 10.023 29.708 0.50 11.38 O Unresolved disorder model. using A ATOM 1431 OD1BASP 173 -13.060 10.780 31.685 0.50 12.43 O Unresolved disorder model. using A ATOM 1432 OD2AASP 173 -10.654 9.594 31.070 0.50 12.43 O Unresolved disorder model. using A ATOM 1433 OD2BASP 173 -11.675 11.728 33.112 0.50 13.03 O Unresolved disorder model. using A ATOM 1460 CG AGLN 177 -16.915 15.012 34.517 0.50 11.28 C Unresolved disorder model. using A ATOM 1461 CG BGLN 177 -16.237 13.907 33.757 0.50 11.10 C Unresolved disorder model. using A ATOM 1462 CD AGLN 177 -17.816 13.778 34.463 0.50 12.58 C Unresolved disorder model. using A ATOM 1463 CD BGLN 177 -16.004 13.897 35.254 0.50 12.95 C Unresolved disorder model. using A ATOM 1464 OE1AGLN 177 -17.447 12.747 33.903 0.50 14.17 O Unresolved disorder model. using A ATOM 1465 OE1BGLN 177 -15.443 14.841 35.815 0.50 14.13 O Unresolved disorder model. using A ATOM 1466 NE2AGLN 177 -18.996 13.879 35.063 0.50 14.33 N Unresolved disorder model. using A ATOM 1467 NE2BGLN 177 -16.442 12.834 35.913 0.50 13.33 N Unresolved disorder model. using A ATOM 1866 CD1AILE 229 5.563 0.658 12.173 0.50 5.86 C Unresolved disorder model. using A ATOM 1867 CD1BILE 229 6.871 2.708 12.156 0.50 6.42 C Unresolved disorder model. using A ATOM 2129 CD1AILE 262 13.215 14.329 -17.315 0.50 5.92 C Unresolved disorder model. using A ATOM 2130 CD1BILE 262 11.883 16.383 -17.762 0.50 6.80 C Unresolved disorder model. using A ATOM 2262 CB AASP 278 -9.317 28.369 -32.306 0.50 12.57 C Unresolved disorder model. using A ATOM 2263 CB BASP 278 -9.356 28.336 -32.319 0.50 12.35 C Unresolved disorder model. using A ATOM 2264 CG AASP 278 -10.755 27.936 -32.066 0.50 13.78 C Unresolved disorder model. using A ATOM 2265 CG BASP 278 -9.213 29.645 -31.536 0.50 12.73 C Unresolved disorder model. using A ATOM 2266 OD1AASP 278 -11.599 28.832 -31.850 0.50 16.04 O Unresolved disorder model. using A ATOM 2267 OD1BASP 278 -10.134 30.488 -31.632 0.50 14.43 O Unresolved disorder model. using A ATOM 2268 OD2AASP 278 -11.054 26.719 -32.101 0.50 13.74 O Unresolved disorder model. using A ATOM 2269 OD2BASP 278 -8.198 29.848 -30.835 0.50 13.05 O Unresolved disorder model. using A ATOM 2503 CA AASP 307 7.891 19.347 -17.992 0.50 5.61 C Unresolved disorder model. using A ATOM 2504 CA BASP 307 7.840 19.361 -17.992 0.50 5.77 C Unresolved disorder model. using A ATOM 2507 CB AASP 307 9.215 18.961 -18.650 0.50 6.40 C Unresolved disorder model. using A ATOM 2508 CB BASP 307 9.093 19.072 -18.821 0.50 6.64 C Unresolved disorder model. using A ATOM 2509 CG AASP 307 9.099 18.715 -20.134 0.50 7.75 C Unresolved disorder model. using A ATOM 2510 CG BASP 307 9.837 20.335 -19.219 0.50 9.25 C Unresolved disorder model. using A ATOM 2511 OD1AASP 307 7.979 18.755 -20.684 0.50 10.10 O Unresolved disorder model. using A ATOM 2512 OD1BASP 307 9.183 21.389 -19.385 0.50 12.28 O Unresolved disorder model. using A ATOM 2513 OD2AASP 307 10.163 18.473 -20.749 0.50 10.87 O Unresolved disorder model. using A ATOM 2514 OD2BASP 307 11.075 20.280 -19.367 0.50 12.80 O Unresolved disorder model. using A ATOM 2757 CA ALEU 339 7.342 12.894 -10.158 0.50 3.93 C Unresolved disorder model. using A ATOM 2758 CA BLEU 339 7.325 12.886 -10.164 0.50 4.00 C Unresolved disorder model. using A ATOM 2761 CB ALEU 339 6.826 14.288 -9.752 0.50 4.36 C Unresolved disorder model. using A ATOM 2762 CB BLEU 339 6.707 14.249 -9.834 0.50 4.43 C Unresolved disorder model. using A ATOM 2763 CG ALEU 339 7.717 15.262 -8.970 0.50 4.96 C Unresolved disorder model. using A ATOM 2764 CG BLEU 339 7.377 15.473 -9.255 0.50 5.38 C Unresolved disorder model. using A ATOM 2765 CD1ALEU 339 7.157 16.696 -9.033 0.50 4.86 C Unresolved disorder model. using A ATOM 2766 CD1BLEU 339 8.228 16.127 -10.313 0.50 6.80 C Unresolved disorder model. using A ATOM 2767 CD2ALEU 339 7.901 14.830 -7.538 0.50 5.55 C Unresolved disorder model. using A ATOM 2768 CD2BLEU 339 6.265 16.410 -8.820 0.50 4.03 C Unresolved disorder model. using A ATOM 3298 CB ASER 407 -14.778 -16.653 -2.508 0.50 10.42 C Unresolved disorder model. using A ATOM 3299 CB BSER 407 -14.773 -16.671 -2.523 0.50 10.34 C Unresolved disorder model. using A ATOM 3300 OG ASER 407 -14.128 -17.304 -1.430 0.50 12.19 O Unresolved disorder model. using A ATOM 3301 OG BSER 407 -15.999 -16.088 -2.123 0.50 10.55 O Unresolved disorder model. using A ATOM 3749 CD1AILE 462 -25.791 -1.060 -11.697 0.50 9.39 C Unresolved disorder model. using A ATOM 3750 CD1BILE 462 -24.723 -2.736 -12.610 0.50 8.79 C Unresolved disorder model. using A ATOM 3771 CB AILE 466 -15.503 -3.579 -3.728 0.50 7.28 C Unresolved disorder model. using A ATOM 3772 CB BILE 466 -15.159 -3.248 -3.981 0.50 7.14 C Unresolved disorder model. using A ATOM 3773 CG1AILE 466 -14.398 -3.336 -4.742 0.50 6.69 C Unresolved disorder model. using A ATOM 3774 CG1BILE 466 -16.417 -3.880 -4.590 0.50 8.24 C Unresolved disorder model. using A ATOM 3775 CG2AILE 466 -16.894 -3.704 -4.351 0.50 8.13 C Unresolved disorder model. using A ATOM 3776 CG2BILE 466 -14.048 -4.271 -3.805 0.50 8.00 C Unresolved disorder model. using A ATOM 3777 CD1AILE 466 -14.159 -4.513 -5.660 0.50 6.61 C Unresolved disorder model. using A ATOM 3778 CD1BILE 466 -16.376 -4.028 -6.114 0.50 8.94 C Unresolved disorder model. using A ATOM 3919 CD1AILE 485 6.876 15.626 -4.971 0.50 6.87 C Unresolved disorder model. using A ATOM 3920 CD1BILE 485 5.638 17.701 -4.984 0.50 6.93 C 1